Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities

Medicine & Life Sciences

• Chemotactic Factors 100%
• ErbB Receptors 84%
• Non-Small Cell Lung Carcinoma 79%
• Leukocytes 70%
• Lewis Lung Carcinoma 21%
• Protein-Tyrosine Kinases 14%
• Neoplasm Metastasis 12%
• SCID Mice 12%
• Gene Amplification 6%
• Extracellular Signal-Regulated MAP Kinases 5%
• Phosphatidylinositol 3-Kinase 5%
• Growth 5%
• Immunoprecipitation 5%
• Knockout Mice 4%
• Heterografts 4%
• In Vitro Techniques 4%
• Cell Movement 4%
• Therapeutics 4%
• Psychological Inhibition 4%
• Hepatocellular Carcinoma 4%
• Lung Neoplasms 4%
• Cell Survival 3%
• Enzyme-Linked Immunosorbent Assay 3%
• Western Blotting 3%
• Aptitude 3%
• Cell Proliferation 3%
• Neoplasms 3%
• Cytokines 3%
• Drug Therapy 3%
• Mutation 2%
• Proteins 1%